Aspire Fertility is proud to announce a new partnership between our parent company, Inception Fertility Ventures and Houston Fertility Specialists (HFS). This new partnership allows us to help even more families throughout the Houston area, with new locations in Houston, Sugar Land, Katy, Webster, and Clear Lake to better serve you.

Houston Fertility Specialists is one of the largest fertility centers in the United States with more than 7,000 babies born as a result of their dedication and experience.

“HFS is an impressive operation with an amazing team of physicians, nurses, and support staff, and we couldn’t have chosen a better partner. We will work closely together to seamlessly merge our exceptional clinical services while expanding our geographic presence,” says TJ Farnsworth, Inception’s Founder and CEO. He adds, “The true strength of our partnership is that Aspire and HFS share a vision in that our common purpose is to achieve the highest bar in patient experience, science, and medicine—no exceptions.”

A Shared Vision

“We share a common culture that our patient’s experience is just as important as their outcome,” says HFS managing partner, Dr. Randall Dunn. “This shared vision of focusing on the patient experience made combining our practices together a great way to bring our expertise and the Aspire Way to even more families throughout Texas.”

The Providers at HFS

Our new Aspire providers have a 30-year history in Houston. The team includes Dr. George M. Grunert, Dr. Randall C. Dunn, Dr. R.K. Mangal, Dr. Leah Schenk, Dr. Subodh Chauhan, Dr. Ertug Kovanci and Dr. Yanett Anaya. Their Lab Director is Dr. Wan-Song Alfred Wun. Together, they have served Houston as the longest-running infertility practice in the Southwest.

What does the change mean to our patients?

The biggest change is that we have even more locations for your convenience. You’ll still have access to the quality and personalized care that Aspire Fertility is known for. All of your frozen embryos, sperm and eggs will remain safe and well-cared for.

If you have any questions about this partnership and what it will mean for your care, please don’t hesitate to contact us at (713) 300-1123 or 713-512-7900 to speak with one of our staff members.

We look forward to continuing to serve you in your dream to build your family!




Radio Frequency Identification Tags virtually eliminate patient concern about becoming separated
from their own eggs, sperm, or embryos throughout the fertility process.

HOUSTON, Texas (August 25, 2016) —Aspire Fertility is among the first Fertility Clinics in the United States to launch RI Witness™ in its Assisted Reproductive Technology (ART) labs—a technologically advanced system that locks a patient’s identity to their eggs, sperm, or embryos at every stage of infertility treatment. RI Witness automatically tracks and records every piece of patient data, and creates a comprehensive record of each patient’s samples, making it the most simple, but indispensable, component of the ART management system.

RI Witness technology uses non-invasive Radio Frequency Identification (RFID) tags to track each patient’s eggs, sperm, and embryos throughout the duration of treatment. Tag readers are integrated into workstations where samples are transferred between containers, providing the essential controls necessary to ensure eggs, sperm, and embryos are correctly matched and treated. If plasticware containing samples of incompatible origin come into contact any stage of the cycle, the system activates an alarm and prompts the embryologist to halt the procedure and respond.

The RFID tag reader’s unique design ensures clinicians are working on only one set of samples at a time, that correct samples are being used, and that appropriate protocols are being followed. They also ensure samples are continually maintained at the appropriate temperature. The resulting controlled and fail-safe working environment virtually eliminates the risk of mixed or improperly handled samples, providing an extra layer of security.

Other non-manual witnessing systems typically rely on embryologists to request a sample check, but these samples give only a tiny snapshot of the sample’s whereabouts when out of the incubator. In contrast, RI Witness automatically identifies all samples, so that no tagged plasticware goes unchecked.

“We couldn’t be more excited to introduce this technology into our labs,” adds TJ Farnsworth, Aspire Fertility founder and CEO. “By introducing a system that verifies established safety protocols, RI Witness gives our lab technicians, our embryologists, and most importantly—our patients—peace of mind.”

Aspire Fertility is a subsidiary of Inception Fertility, headquartered in Houston, Texas. The company’s mission is to shift the paradigm of the IVF market by raising the standard of care, streamlining fragmented components into an integrated system, and enhancing the overall patient experience. In business since 2015, the company operates facilities in Houston, TX and Dallas, TX, with an Atlanta facility projected to open early 2017. For more information about Aspire Fertility, please call 713.300,1123 or visit